Copyright
©The Author(s) 2016.
World J Clin Infect Dis. May 25, 2016; 6(2): 6-21
Published online May 25, 2016. doi: 10.5495/wjcid.v6.i2.6
Published online May 25, 2016. doi: 10.5495/wjcid.v6.i2.6
Study characteristics | Krishnan and Zeichner[18] | Iglesias-Ussel et al[19] | Mohammadi et al[42] | Evans et al[76] |
Cells used | Cell lines ACH-2, A3.01, J1.1 | Primary CD4+ T cells | Primary CD4+ T cells co-cultured with feeder H80 human brain tumor cell line | Primary resting CD4+ T cells co-cultured with dendritic cells |
Virus used | CXCR4 tropic HIV-1 LAV strain | CXCR4 tropic GFP reporter virus (GFP inserted in place of Nef) | CXCR4 tropic GFP reporter virus with mutations in Gag, Vif, Vpr, Vpu, Env and Nef | CCR5 tropic GFP reporter virus (GFP inserted into the Nef open reading frame) |
Proportion of uninfected cells | ≤ 1.1% | 0% | 8%-18% | 99.7% |
Proportion of GFP+ or p24+ cells | 8.20% | 8.15% | Approximately 16% | 0% (removed by sorting) |
Proportion of latently infected cells | 98.9% | 100% | Approximately 82%-92% | Approximately 0.3% |
Time of culture | N/A (chronically infected) | 20-22 d | 13 wk | 5 d |
Experiment replicates | 8 | 4 | Not reported | 4 |
Gene expression profiling platform | Microarrays (Hs. UniGem2) | Microarrays (Agilent-012391 Whole Human Genome Oligo Microarray G4112A) | RNA-Seq (polyA RNA library; Illumina HiSeq2000) | Microarrays (Illumina Human-Ref8) |
Method to identify DEGs | Parametric one-sample random variance t-test (BRB-Array Tools, P < 0.001) | Linear modeling and using an empirical Bayes method with FDR correction (limma) | Generalized linear modeling (DESeq, FDR < 0.05) | Linear modeling and using an empirical Bayes method (limma, FDR < 0.05) |
Databases used for functional analyses | NIH mAdb | GO consortium; | Reactome pathways Ver.40; | IPA |
MsigDb; | MsigDb | |||
KEGG pathways | ||||
Total number of DEGs | 32 | 875 | 227 | Not reported |
- Citation: White CH, Moesker B, Ciuffi A, Beliakova-Bethell N. Systems biology applications to study mechanisms of human immunodeficiency virus latency and reactivation. World J Clin Infect Dis 2016; 6(2): 6-21
- URL: https://www.wjgnet.com/2220-3176/full/v6/i2/6.htm
- DOI: https://dx.doi.org/10.5495/wjcid.v6.i2.6